Citigroup Initiates Coverage On ProKidney with Buy Rating, Announces Price Target of $16
Citigroup analyst Yigal Nochomovitz initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $16.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
OpGen (NASDAQ:OPGN) shares rose 20.6% to $0.52 during Monday's after-market session. This security traded at a volume of 927.4K shares come close, making up 324.6% of its average volume over the last 100 days. The company's market cap stands at $25.0 million.
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Evercore ISI Group Initiates Coverage On ProKidney with Outperform Rating
Evercore ISI Group analyst Jonathan Miller initiates coverage on ProKidney (NASDAQ:PROK) with a Outperform rating.
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Gainers
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1.